GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Pre-Tax Income

Sernova Biotherapeutics (FRA:PSH0) Pre-Tax Income : €-18.97 Mil (TTM As of Jan. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Sernova Biotherapeutics's pretax income for the three months ended in Jan. 2025 was €-3.82 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2025 was €-18.97 Mil. Sernova Biotherapeutics's pretax margin was %.


Sernova Biotherapeutics Pre-Tax Income Historical Data

The historical data trend for Sernova Biotherapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Pre-Tax Income Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.42 -4.83 -18.11 -26.93 -21.48

Sernova Biotherapeutics Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.66 -6.78 -5.07 -3.31 -3.82

Competitive Comparison of Sernova Biotherapeutics's Pre-Tax Income

For the Biotechnology subindustry, Sernova Biotherapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Pre-Tax Income falls into.


;
;

Sernova Biotherapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Sernova Biotherapeutics's Pretax Income for the fiscal year that ended in Oct. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-21.129+-0.216+-0.392+0.259+0.0010000000000012
=-21.48

Sernova Biotherapeutics's Pretax Income for the quarter that ended in Jan. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.222+-0.455+-0.158+0.015+0.00099999999999989
=-3.82

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-18.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics  (FRA:PSH0) Pre-Tax Income Explanation

Sernova Biotherapeutics's Pretax Margin for the quarter that ended in Jan. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.819/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines